The FDA announced that it granted two additional approvals to Syneron Medical Ltd. and its North American subsidiary, Syneron Inc., for the company's hair removal and skin rejuvenation devices.
The Weekly Roundup: May 29-June 2
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
WHO Calls For Caution When it Comes to Using AI For Health
The Cutaneous Connection: JAK Inhibitor Safety for Treating AD
European Commission Approves Secukinumab for Hidradenitis Suppurativa
Addressing Disparities and Ensuring Equitable Care for LGBTQIA+ Patients
2 Clarke Drive Cranbury, NJ 08512